← FDA DRUG APPROVALS

FDA ANDA · ANDA090368

FLUOROURACIL

Sponsor: TARO

APPLICATION
ANDA090368
TYPE
ANDA
ORIGINAL APPROVAL
2010-03-05
LATEST ACTION
2024-01-30
ROUTE
TOPICAL
DOSAGE FORM
CREAM
MARKETING STATUS
Prescription

Products

FLUOROURACILPrescription
FLUOROURACIL 5% · CREAM · TOPICAL

Approval history

2024-01-30Labeling · Supplement 12 · standardAP
2022-11-07Labeling · Supplement 11 · standardAP
2010-03-05OriginalAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →